New Therapeutic Applications of Phosphodiesterase 5 Inhibitors (PDE5-Is)

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|23|12|1239-1249

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.23, Iss.12, 2016-05, pp. : 1239-1249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PDE5 Inhibitors and their Applications

By  

Current Medicinal Chemistry, Vol. 17, Iss. 24, 2010-08 ,pp. : 2564-2587

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction

By Dorsey Philip   Keel Christopher   Klavens Meghan   Hellstrom Wayne JG  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 7, 2010-05 ,pp. : 1109-1122

Informa Healthcare

Access to resources Recommend Favorite

Novel phosphodiesterase-5 (PDE5) inhibitors in the alleviation of erectile dysfunction due to diabetes and ageing-induced oxidative stress

By Gur Serap   Sikka Suresh C   Hellstrom Wayne JG  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 6, 2008-06 ,pp. : 855-864

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of PDE1 and PDE5 cGMP phosphodiesterases: patents and therapeutic potential

By Sybertz E.   Czarniecki M.  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 6, 1997-06 ,pp. : 631-639

Informa Healthcare

Access to resources Recommend Favorite

PDE-5 Inhibitors: Clinical Points

By  

Current Drug Targets, Vol. 16, Iss. 5, 2015-05 ,pp. : 420-426

Bentham Science Publishers

Access to resources Recommend Favorite